ATI RN
ATI RN Pharmacology Exam 2024 With NGN Questions
Extract:
Question 1 of 5
Which of the following medication prescriptions should the nurse identify as being complete?
Correct Answer: C
Rationale: The correct answer is C: Digoxin 0.25 mg PO daily. This prescription is complete because it includes the medication name (Digoxin), dose (0.25 mg), route (PO for orally), and frequency (daily). The dose is specific, and the frequency is clear.
Choice A (Tetracycline) lacks frequency information.
Choice B (Epoetin alfa) lacks route and frequency details.
Choice D (Cimetidine) lacks dose and frequency specifics.
Therefore,
Choice C is the only complete prescription as it includes all necessary information for safe and accurate administration.
Question 2 of 5
Which of the following adverse effects should the nurse include in the teaching for a client who is to begin taking tamoxifen for the treatment of breast cancer?
Correct Answer: D
Rationale: The correct answer is D: Hot flashes. Tamoxifen is known to cause hot flashes as a common adverse effect due to its impact on estrogen receptors. This is important for the nurse to include in teaching as it helps prepare the client for this potential side effect.
A: Urinary retention - Not a common adverse effect of tamoxifen.
B: Constipation - Not a common adverse effect of tamoxifen.
C: Bradycardia - Not a common adverse effect of tamoxifen.
In summary, hot flashes are a common adverse effect of tamoxifen due to its anti-estrogenic properties, making it important for the nurse to educate the client on this potential side effect.
Question 3 of 5
Which of the following actions is the priority for the nurse to take after inadvertently administering 160 mg of valsartan PO to a client who was scheduled to receive 80 mg?
Correct Answer: A
Rationale: The correct answer is A: Evaluate the client for orthostatic hypotension. After administering double the prescribed dose of valsartan, the nurse's priority is to assess the client for potential adverse effects, such as a sudden drop in blood pressure leading to orthostatic hypotension. This is crucial for immediate intervention to prevent complications.
B: Monitoring urine output is important but not the priority after an overdose.
C: Obtaining laboratory results may be necessary later but is not the immediate action needed.
D: Checking for nasal congestion is unrelated to the overdose of valsartan.
In summary, choice A is correct as it addresses the immediate concern of potential adverse effects, while the other choices are not the priority given the situation.
Question 4 of 5
For which of the following adverse effects should the nurse instruct the client taking acetazolamide for chronic open-angle glaucoma to monitor and report?
Correct Answer: A
Rationale: The correct answer is A, tingling of fingers. Acetazolamide is a diuretic that can lead to electrolyte imbalances, such as hypokalemia, causing tingling sensations in the extremities. Constipation (
B) is not a common side effect of acetazolamide. Weight gain (
C) is unlikely as acetazolamide is a diuretic that typically causes fluid loss. Oliguria (
D) is not a typical adverse effect of acetazolamide, as it is more likely to increase urine output.
Question 5 of 5
A nurse is teaching a client about cyclobenzaprinWhich of the following client statements should indicate to the nurse that the teaching is effective?
Correct Answer: C
Rationale:
Correct Answer: C - "I will taper off the medication before discontinuing it."
Rationale: Tapering off cyclobenzaprine is essential to prevent withdrawal symptoms due to its muscle relaxant properties. Abrupt discontinuation can lead to adverse effects. This statement shows understanding of the proper discontinuation process, indicating effective teaching.
Summary:
A: Increased saliva production is not a common side effect of cyclobenzaprine, so it does not demonstrate understanding of the medication.
B: Continuing the medication until the rash disappears is unrelated to cyclobenzaprine's use and does not reflect knowledge of proper medication management.
D: Reporting urinary incontinence is important, but not specific to cyclobenzaprine teaching. It does not indicate understanding of how to discontinue the medication properly.